CRP and COVID-19: Another study conducted by Novacescu and his team, with a focus on using therapeutic plasma exchange followed by convalescent plasma transfusion in severe and critically ill COVID-19 patients, observed a significant decrease in CRP in the treatment group with an increase in survival days [68].